- 作者：Raquel S¨¢nchez-Santos ; F¨¢tima Sabench Pereferrer ; Sergio Est¨¦vez Fern ; ez ; Daniel del Castillo Dejardin ; Nuria Vilarrasa ; Dolores Frutos Bernal ; Juan Carlos Ruiz de Adana ; Carlos Masdevall Noguera ; Antonio Torres Garc¨ªa
- 关键词：Coste-efectividad ; Obesidad mó ; rbida ; Coste-utilidad ; Cirugí ; a bariá ; trica
- 刊名：Ciruga Espa?ola
- 出版年：2013
- 出版时间：October, 2013
- 年：2013
- 卷：91
- 期：8
- 页码：476-484
- 全文大小：686 K
Morbid obesity is a serious health problem whose prevalence is increasing. Expensive co-morbidities are associated to these patients, as well as a reduction in the survival. Bariatric surgery resolves the co-morbidities (type 2 diabetes mellitus, 86.6 % ; cardiovascular risk, 79.0 % ; obstructive sleep apnea syndrome, 83.6 % ; hypertension, 61.7 % ), reduces the mortality rate (among 31-40 % ), and increases the morbid obese patients survival over a 10-years period. It provides significant savings for the National Health System. The obese patients consume a 20 % plus of health resources and 68 % plus of drugs than general population. Bariatric surgery requires an initial investment (diagnosis-related group cost: 7,468 ), but it is recovered in a cost-effectiveness ratio of 2.5 years. Significant savings are obtained from the third year. To the direct economic benefits associated with reduced health expenditures it should be added an increase in tax collection (sick leave and unemployment reduction is estimated in 18 % , with a productivity increase of 57 % for self-employed people). Bariatric surgery is one of the most cost-effective procedures in the healthcare system.